Connect with us

Tech

8 Stocks to Watch for the NBA’s 75th Anniversary Season

Published

on

The National Basketball Association kicked off its 75th season Oct. 19 with a doubleheader featuring four of the top teams in the league.
As the NBA season kicks off in full force, here is a look at some of the publicly traded companies that could get a boost from the new season.
1. Madison Square Garden Sports: Publicly traded Madison Square Garden Sports (NYSE: MSGS) is the owner of several sports teams including the NBA’s New York Knicks. The company also owns the NHL’s New York Rangers.
Sportico ranks the Knicks first in NBA team valuation at $5.42 billion. The team is one of three, along with the Golden State Warriors ($5.21 billion) and Los Angeles Lakers ($5.14 billion), to be valued at more than five billion dollars. Forbes values the Knicks at $5 billion, also coming in first on its list.
The Knicks have lost 70% of their games in the past six seasons and won only one NBA Playoff series since 2000. Despite the many losing records, the team still generates a ton of fans at games and gets huge viewership on television.
The team finished with a 41-31 record last year, fourth in the Eastern Conference. The Knicks lost in the first round of the NBA Playoffs last year. A strong finish by the team in back-to-back seasons could continue to boost the valuation and revenue of the Knicks.
2. Madison Square Garden Entertainment: The owner of the namesake Madison Square Garden is Madison Square Garden Entertainment (NYSE: MSGE).
The company owns the arena that will enjoy a financial boost from the return of fans to Rangers games. MSGE is also the parent company of MSG Network and MSG+, two media channels that air Knicks games and …
Full story available on Benzinga.comRead More

Original Source: benzinga.com

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Tech

Mereo BioPharma’s Etigilimab/Opdivo Combo Achieves One Complete Response in Cervical Cancer

Published

on

Mereo BioPharma Group plc (NASDAQ: MREO) reported interim data from ACTIVATE Phase 1b/2 study of its anti-TIGIT antibody, etigilimab, in combination with Bristol Myers Squibb Co (NYSE: BMY) Opdivo (nivolumab) in select recurrent advanced/metastatic solid tumors.
As of the cut-off date, one complete response in cervical cancer, one partial response in ovarian cancer, and four …
Full story available on Benzinga.comRead More

Original Article: benzinga.com

Continue Reading

Tech

Canada Plastics Pact Welcomes 15 New Partners

Published

on

OTTAWA, Nov. 30, 2021 (GLOBE NEWSWIRE) — Canada Plastics Pact is excited to be welcoming 15 new Partners following last month’s release of it’s shared action plan to build a circular economy for plastics packaging in Canada. The new Partners announced today include leading consumer goods organizations, provincial and municipal governments, resin producers, recyclers, a bio-based plastics startup, one of Canada’s largest waste management companies, a new non-profit Producer Responsibility Organization and leading non-profit organizations from across the country.
Since the CPP launched in January 2021, the CPP has doubled in size to include 81 leading industry, NGO, and public sector organizations who together account for over a third of the plastics packaging in the market nationally. These Partners are working collaboratively towards ambitious 2025 targets to create a circular economy for plastics packaging in Canada where it stays in the economy and out of the environment. This has included the release of Roadmap to 2025: A shared action plan to build a circular economy for plastics …
Full story available on Benzinga.comRead More

Article: benzinga.com

Continue Reading

Tech

HealthRecon Connect Successfully Completes SOC 1(R) Type 1 Examination

Published

on

DALLAS, Nov. 30, 2021 (GLOBE NEWSWIRE) — HealthRecon Connect, leading revenue cycle management solutions provider to Healthcare Providers based in the US, reaffirmed its commitment to internal security controls by successfully completing the System and Organizational Controls SOC 1(R) Type 1 examination. The report independently audited by Stakes CPA, LLC, validates that HealthRecon’s infrastructure, controls, policies, and procedures meet and/or exceeded the SOC 1(R) Type 1 criteria as of July 1, …
Full story available on Benzinga.comRead More

Source Here: benzinga.com

Continue Reading

Trending

BaypointNews.com